Tissue Regenix Group Plc Financial Flexibility Index
Tissue Regenix Group Plc financial flexibility index. Tissue Regenix Group Plc (TRX) has a Financial Flexibility Index of -0.01x as of June 2025. Free cash flow of GBX-152.00K (operating CF GBX-202.00K minus capex GBX50.00K) represents 0% of total liabilities (GBX18.56 Million). See TRX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Tissue Regenix Group Plc (2008–2024)
Financial flexibility index of Tissue Regenix Group Plc from 2008 to 2024. Historical Financial Flexibility Index trend for Tissue Regenix Group Plc across 19 annual periods. Check how high is Tissue Regenix Group Plc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Tissue Regenix Group Plc Financial Flexibility Index by Year (2008–2024)
Tissue Regenix Group Plc financial flexibility index by year from 2008 to 2024. Year-by-year free cash flow to debt coverage for Tissue Regenix Group Plc. For the full cash flow conversion analysis, see Tissue Regenix Group Plc operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.15x | GBX2.43 Million | GBX-1.64 Million | GBX16.29 Million | ▲ +9.0% |
| 2023 | 0.14x | GBX1.90 Million | GBX1.04 Million | GBX13.89 Million | ▲ +535.4% |
| 2022 | -0.03x | GBX-409.10K | GBX-1.29 Million | GBX13.00 Million | ▲ +79.9% |
| 2021 | -0.16x | GBX-1.49 Million | GBX-2.98 Million | GBX9.47 Million | ▲ +70.2% |
| 2020 | -0.53x | GBX-4.68 Million | GBX-6.05 Million | GBX8.88 Million | ▲ +51.4% |
| 2019 | -1.08x | GBX-6.40 Million | GBX-7.05 Million | GBX5.90 Million | ▲ +13.2% |
| 2018 | -1.25x | GBX-6.36 Million | GBX-6.77 Million | GBX5.09 Million | ▲ +18.5% |
| 2018 | -1.53x | GBX-9.56 Million | GBX-9.79 Million | GBX6.24 Million | ▼ -0.5% |
| 2017 | -1.53x | GBX-9.52 Million | GBX-9.74 Million | GBX6.24 Million | ▲ +67.4% |
| 2016 | -4.68x | GBX-9.66 Million | GBX-10.70 Million | GBX2.06 Million | ▼ -12.1% |
| 2016 | -4.17x | GBX-11.63 Million | GBX-12.65 Million | GBX2.79 Million | ▲ +42.9% |
| 2015 | -7.31x | GBX-8.00 Million | GBX-8.12 Million | GBX1.09 Million | ▼ -52.6% |
| 2014 | -4.79x | GBX-8.72 Million | GBX-9.31 Million | GBX1.82 Million | ▲ +16.9% |
| 2013 | -5.76x | GBX-6.24 Million | GBX-6.48 Million | GBX1.08 Million | ▼ -78.5% |
| 2012 | -3.23x | GBX-3.29 Million | GBX-3.34 Million | GBX1.02 Million | ▲ +40.6% |
| 2011 | -5.44x | GBX-2.18 Million | GBX-2.34 Million | GBX400.37K | ▲ +23.3% |
| 2010 | -7.09x | GBX-362.65K | GBX-362.65K | GBX51.12K | ▲ +15.8% |
| 2009 | -8.43x | GBX-510.22K | GBX-510.22K | GBX60.53K | ▼ -27.3% |
| 2008 | -6.62x | GBX-552.80K | GBX-556.78K | GBX83.52K | — |